Maryam Ghasemi‐Kasman

ORCID: 0000-0002-5014-5166
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurogenesis and neuroplasticity mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Alzheimer's disease research and treatments
  • MicroRNA in disease regulation
  • Pluripotent Stem Cells Research
  • Curcumin's Biomedical Applications
  • Global Health Care Issues
  • Sphingolipid Metabolism and Signaling
  • Effects and risks of endocrine disrupting chemicals
  • Multiple Sclerosis Research Studies
  • Nerve injury and regeneration
  • Anesthesia and Neurotoxicity Research
  • Long-Term Effects of COVID-19
  • Reproductive System and Pregnancy
  • Health disparities and outcomes
  • Global Maternal and Child Health
  • Advanced Nanomaterials in Catalysis
  • Global Public Health Policies and Epidemiology
  • Mesenchymal stem cell research
  • Pregnancy and Medication Impact
  • Tryptophan and brain disorders
  • COVID-19 Clinical Research Studies
  • Metal-Organic Frameworks: Synthesis and Applications
  • Climate Change and Health Impacts
  • Medicinal Plants and Neuroprotection

Babol University of Medical Sciences
2016-2025

Institute for Health Metrics and Evaluation
2018-2019

Auckland University of Technology
2019

University of Washington
2018-2019

Cellular Research (United States)
2017

Tarbiat Modares University
2012-2017

Emma Nichols Cassandra Szoeke Dan J. Stein Nooshin Abbasi Foad Abd-Allah and 95 more Jemal Abdela Miloud Taki Eddine Aichour Rufus Akinyemi Fares Alahdab Solomon Weldegebreal Asgedom Ashish Awasthi Suzanne Barker‐Collo Bernhard T. Baune Yannick Béjot Abate Bekele Belachew Derrick Bennett Belete Biadgo Ali Bijani Muhammad Shahdaat Bin Sayeed Carol Brayne David O. Carpenter Félix Carvalho Ferrán Catalá-López Ester Cerin Jee-Young J Choi Anh Kim Dang Meaza Girma Degefa Shirin Djalalinia Manisha Dubey Eyasu Ejeta Duken David Edvardsson Matthias Endres Sharareh Eskandarieh André Faro Farshad Farzadfar Seyed-Mohammad Fereshtehnejad Eduarda Fernandes Irina Filip Florian Fischer Abadi Kahsu Gebre Demeke Geremew Maryam Ghasemi‐Kasman E. V. Gnedovskaya Rajeev Gupta Vladimir Hachinski Tekleberhan B Hagos Samer Hamidi Graeme J. Hankey Josep María Haro Simon I Hay Seyed Sina Naghibi Irvani Ravi Prakash Jha Jost B. Jonas Rizwan Suliankatchi Abdulkader André Karch Amir Kasaeian Yousef Khader Fakher Rahim Ejaz Ahmad Khan Tripti Khanna Tawfik Khoja Jagdish Khubchandani Adnan Kısa Katarzyna Kissimova‐Skarbek Mika Kivimäki Ai Koyanagi Kristopher J Krohn Giancarlo Logroscino Stefan Lorkowski Marek Majdán Reza Malekzadeh Winfried März João Massano Getnet Mengistu Atte Meretoja Moosa Mohammadi Maryam Mohammadi‐Khanaposhtani Ali H. Mokdad Stefania Mondello Ghobad Moradi Gabriele Nagel Mohsen Naghavi Gurudatta Naik Long Hoang Nguyen Trang Huyen Nguyen Yirga Legesse Nirayo Molly R Nixon Richard Ofori‐Asenso Felix Akpojene Ogbo Andrew T Olagunju Mayowa Owolabi Songhomitra Panda‐Jonas Valéria Maria de Azeredo Passos David M. Pereira Gabriel David Pinilla-Monsalve М. А. Пирадов Constance D Pond Hossein Poustchi Mostafa Qorbani Amir Radfar

BackgroundThe number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding disease burden. We aimed present first detailed analysis global prevalence, mortality, overall burden as captured by Global Burden Diseases, Injuries, Risk Factors (GBD) Study 2016, highlight most important messages for clinicians neurologists.MethodsGBD 2016...

10.1016/s1474-4422(18)30403-4 article EN cc-by The Lancet Neurology 2018-11-26
Ettore Beghi Giorgia Giussani Emma Nichols Foad Abd-Allah Jemal Abdela and 95 more Ahmed Abdelalim Haftom Niguse Abraha Mina G Adib Sutapa Agrawal Fares Alahdab Ashish Awasthi Yohanes Ayele Miguel A. Barboza Abate Bekele Belachew Belete Biadgo Ali Bijani Helen Bitew Félix Carvalho Yazan Chaiah Ahmad Daryani Huyen Phuc Manisha Dubey Aman Yesuf Endries Sharareh Eskandarieh André Faro Farshad Farzadfar Seyed‐Mohammad Fereshtehnejad Eduarda Fernandes Daniel Obadare Fijabi Irina Filip Florian Fischer Abadi Kahsu Gebre Afewerki Gebremeskel Tsadik Teklu Gebrehiwo Gebremichael Kebede Embaye Gezae Maryam Ghasemi‐Kasman Kidu Gidey Meaza Girma Degefa E. V. Gnedovskaya Tekleberhan B Hagos Arvin Haj‐Mirzaian Arya Haj‐Mirzaian Hamid Yimam Hassen Simon I Hay Mihajlo Jakovljević Amir Kasaeian Tesfaye Kassa Yousef Khader Fakher Rahim Ejaz Ahmad Khan Jagdish Khubchandani Adnan Kısa Kristopher J Krohn Chanda Kulkarni Yirga Legesse Nirayo Mark T. Mackay Marek Majdán Azeem Majeed Treh Manhertz Man Mohan Mehndiratta Tesfa Mekonen Hagazi Gebre Meles Getnet Mengistu Shafiu Mohammed Mohsen Naghavi Ali H. Mokdad Ghulam Mustafa Seyed Sina Naghibi Irvani Long Hoang Nguyen Molly R Nixon Felix Akpojene Ogbo Andrew T Olagunju Tinuke O Olagunju Mayowa Owolabi Michael Phillips Gabriel David Pinilla-Monsalve Mostafa Qorbani Amir Radfar Anwar Rafay Vafa Rahimi‐Movaghar Nickolas Reinig Perminder S. Sachdev Hosein Safari Saeed Safari Saeid Safiri Mohammad Ali Sahraian Abdallah M Samy Shahabeddin Sarvi Monika Sawhney Masood Ali Shaikh Mehdi Sharif Gagandeep Singh Mari Smith Cassandra Szoeke Rafael Tabarés‐Seisdedos Mohamad‐Hani Temsah Omar Temsah Miguel Tortajada‐Girbés Bach Xuan Tran Amanuel Tsegay

Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality residual disability). Data on are needed for health-care planning resource allocation. The aim this study was quantify due by age, sex, year, location using data from Global Burden Diseases, Injuries, Risk Factors Study.We assessed in 195 countries territories 1990 2016. measured as deaths, prevalence, disability-adjusted life-years (DALYs; a summary measure defined...

10.1016/s1474-4422(18)30454-x article EN cc-by The Lancet Neurology 2019-02-14

Background The conversion of astrocytes to neuroblasts holds great promise for treatment neurodegenerative and traumatic brain diseases. Methodology Principal Findings Here we have shown that adult human could be reprogrammed by miR-302/367, both in vivo vitro. However, the reprogramming mouse required valproic acid (VPA), a histone deacetylase inhibitor. Following induction toward neurons expression pluripotency markers were not detected, which suggested direct cell conversion. We did...

10.1371/journal.pone.0127878 article EN cc-by PLoS ONE 2015-06-01

Natural herbal compounds have been widely introduced as an alternative therapeutic approach in cancer therapy. Despite potent anticancer activity of curcumin, its clinical application has limited because low water solubility and resulting poor bioavailability. In this study, we designed a novel ultrasonic-assisted method for the synthesis curcumin-loaded chitosan-alginate-sodium tripolyphosphate nanoparticles (CS-ALG-STPP NPs). Furthermore, antitumor effect NPs was evaluated vitro. Field...

10.2147/ijn.s146516 article EN cc-by-nc International Journal of Nanomedicine 2017-11-01

Enhancement of repair potential for degenerative brain diseases has been a research priority during recent years. Considering advancements in the field direct transdifferentiation, conversion astrocytes as prominent component glial scars to progenitor cells that contribute mechanisms seems interesting. Recently, we have reported miR-302/367-mediated vivo into neuroblasts and neurons. In current study, used miR-302/367 valproate (VPA) show possibility oligodendrocyte myelinating cuprizone...

10.1002/term.2276 article EN Journal of Tissue Engineering and Regenerative Medicine 2017-01-27

Objectives: Recent evidences have shown the beneficial effects of natural products for treating Alzheimer's disease (AD). Arbutin is derived from Pyrus biossieriana and exerts a wide range pharmacological activities including anti-inflammatory anti-oxidant effects. The present study was designed to examine protective arbutin on streptozotocin (STZ)-induced neurotoxicity in rats.Materials methods: spatial memory impairment induced by intracerebroventricular (i.c.v) microinjection STZ (3...

10.1080/00207454.2019.1638376 article EN International Journal of Neuroscience 2019-06-28

Background: Despite the numerous pharmacological activities of quercetin, its biomedical application has been hampered, because poor water solubility and low oral bioavailability.In present study, we fabricated a novel form quercetin-conjugated Fe 3 O 4 -β-cyclodextrin (βCD) nanoparticles (NPs), effect these prepared NPs was evaluated in chronic model epilepsy.Methods: Quercetin-loaded were using an iron oxide core coated with βCD pluronic F68 polymer.The epilepsy developed by...

10.2147/ijn.s218317 article EN cc-by-nc International Journal of Nanomedicine 2019-08-01

Background: Naringin and MCC950 as an inflammasome inhibitor have exhibited numerous pharmacological activities, including antioxidant anti-inflammatory effects. The present study has examined the combined impacts of naringin on levels oxidative stress, demyelination, inflammation in cuprizone (CPZ)-induced demyelination model. Methods: In order to induce CPZ (0.2% w/w) was added normal diet mice for 42 days. Subsequently, male C57BL/6 received (oral administration), (intraperitoneal...

10.2174/1570159x23666241206102022 article EN Current Neuropharmacology 2025-01-07

ABSTRACT Metal–organic frameworks (MOFs) have been gaining significant attention due to their potential application in medicine. Here, we investigated the effect of zeolite imidazole framework‐8 (ZIF‐8) on neuro‐behavioral parameters, histopathology, inflammation, and oxidative stress levels rats' brain samples. Forty‐eight male Wistar rats were injected by four injections saline or ZIF‐8 at different doses 5, 10, 20 mg/kg via caudal vein. Y‐Maze, Morris‐Water Maze (MWM), three chamber tests...

10.1002/tox.24467 article EN Environmental Toxicology 2025-01-07
Coming Soon ...